Keywords: update, dip, 2nd-qtr, net, income, biogen, reported
Update - dip in 2nd-qtr net income for Biogen
Article | 18 July 2001
Biogen has reported a 0.3% decrease in net income for the second quarterof 2001 to $71.9 million, or $0.47 per share, while revenues were $261 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
